Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

Clinical trial NCT03808922 · RECRUITING

Trial details

NCT number: NCT03808922
Sponsor: Ansun Biopharma, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Lower Respiratory Tract Infection Parainfluenza Immunocompromised COVID-19

Start date: 2019-05-23
Primary completion: 2028-09-01
Enrollment: 274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.